BSE will replace Wipro in the Nifty 50 from September 30, with Nuvama estimating $695 million inflows into BSE and $240 million outflows fr...

In a notable change effective September 30, BSE shares will enter the Nifty 50 index, taking over Wipro's longstanding position since Janua...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Sunil Singhania-backed Abakkus Small Cap Fund added Indo-MIM, Mrs Bectors Food Specialities and BEML to its portfolio in July while exiting...

The firm’s revenue from operations meanwhile rose around 28% YoY to Rs 3,080 crore in Q1 FY27, from Rs 2,410 crore reported in the year-ago...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

As per Sebi's T+1 settlement cycle, investors must buy a company's shares at least one trading day before the record date to ensure the sha...

The healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...

Investors must hold shares in their demat accounts on the respective record dates to be eligible. Here is the complete day-wise list of key...

Brokerages expressed caution on frontline IT stocks following June quarter earnings. Citi downgraded HCL Technologies to Sell, citing weak ...

Sunil Singhania-backed Abakkus Flexi Cap Fund exited Vedanta, Vedanta Oil & Gas and Vedanta Iron & Steel following the group's demerger in ...

ICICI Securities recommends a sell on Divi's Laboratories with a target price of Rs 4,500 despite recent quarterly growth. Management remai...

A total of 2,065 shares changed hands on the counter till 01:08PM (IST).

The stock quoted a 52-week high price of Rs 5582.85 and low of Rs 3300.0.

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98115.86 Crore) operating in Pharmace...

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99034.38 Crore) operating in Pharmace...

Promoters held 51.93 per cent stake in the company as of 30-Jun-2023, while FIIs owned 14.69 per cent, DIIs 21.03 per cent.